Clinical Radiology
Volume 63, Issue 8 , Pages 871-879 , August 2008

Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours

  • S. Cirillo

      Affiliations

    • Unit of Radiology, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
    • Corresponding Author InformationGuarantor and correspondent: S. Cirillo, Institute for Cancer Research and Treatment, Unit of Radiology, Strada Provinciale 142, Km. 3.95, 10060 Candiolo, Torino, Italy. Tel.: +39 01199333064; fax: +39 0119933801.
    • ,
  • M. Petracchini

      Affiliations

    • Unit of Radiology, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
    • ,
  • P. Della Monica

      Affiliations

    • Unit of Radiology, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
    • ,
  • T. Gallo

      Affiliations

    • Unit of Radiology, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
    • ,
  • V. Tartaglia

      Affiliations

    • Unit of Radiology, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
    • ,
  • E. Vestita

      Affiliations

    • Department of Urology, Ivrea Hospital, Ivrea, Torino, Italy
    • ,
  • U. Ferrando

      Affiliations

    • San Giovanni Battista Hospital, Department of Urology, Torino, Italy
    • ,
  • D. Regge

      Affiliations

    • Unit of Radiology, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy

Received 19 March 2007 ,Revised 16 October 2007 ,Accepted 21 October 2007.

References 

  1. Crawford ED. Epidemiology of prostate cancer. Urology. 2003;62(6 Suppl 1):3–12
  2. Djavan B, Remzi M, Schulman CC, et al. Repeat prostate biopsy: who, how and when? A review. Eur Urol. 2002;42:93
  3. Roobol MJ, Schroder FH. European randomized study of screening for prostate cancer: achievements and presentation. BJU Int. 2003;92(Suppl. 2):117
  4. Djavan B, Ravery V, Zlotta A, et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?. J Urol. 2001;166:1679
  5. Lujan M, Paez A, Santonja C, et al. Prostate cancer detection and tumor characteristics in men with multiple biopsy sessions. Prostate Cancer Prostatic Dis. 2004;7:238
  6. Hricak H, Wang L, Wei DC, et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer. 2004;100:2655
  7. Kaji Y, Kurhanewicz J, Hricak H, et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology. 1998;206:785
  8. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology. 1999;213:481
  9. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging–clinicopathologic study. Radiology. 1999;213:473
  10. Coakley FV, Kurhanewicz J, Lu Y, et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology. 2002;223:91
  11. Beyersdorff D, Taupitz M, Winkelmann B, et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology. 2002;224:701
  12. Prando A, Kurhanewicz J, Borges AP, et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology. 2005;236:903
  13. Yuen JS, Thng CH, Tan PH, et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol. 2004;171:1482
  14. Amsellem-Ouazana D, Younes P, Conquy S, et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol. 2005;47:582
  15. Wetter A, Hubner F, Lehnert T, et al. Three-dimensional 1H-magnetic resonance spectroscopy of the prostate in clinical practice: technique and results in patients with elevated prostate-specific antigen and negative or no previous prostate biopsies. Eur Radiol 15:645.
  16. Manenti G, Squillaci E, Carlani M, et al. Magnetic resonance imaging of the prostate with spectroscopic imaging using a surface coil. Initial clinical experience. Radiol Med. 2006;111:22
  17. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol. 1991;145:984
  18. Schricker AA, Pauly JM, Kurhanewicz J, et al. Dual-band spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med. 2001;46:1079
  19. Tran TK, Vigneron DB, Sailasuta N, et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med. 2000;43:23
  20. Kurhanewicz J, Vigneron DB, Hricak H, et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology. 1996;200:489
  21. Zackrisson B, Aus G, Bergdahl S, et al. The risk of finding focal cancer (less than 3mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable. J Urol. 2004;171:1487
  22. Zakian KL, Eberhardt S, Hricak H, et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging—initial results. 2003;229:241.
  23. Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology. 1989;172:131
  24. Fournier G, Valeri A, Mangin P, et al. Prostate cancer. Epidemiology. Risk factors. Pathology. Ann Urol (Paris). 2004 Oct;38(5):187–206
  25. Anastasiadis AG, Lichy MP, Nagele U, et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol. 2006;50:738
  26. Beyersdorff D, Winkel A, Hamm B, et al. MR imaging-guided prostate biopsy with a closed MR unit at 1.5T: initial results. Radiology. 2005;234:576
  27. Rabets JC, Jones JS, Patel A, et al. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol. 2004;172:94
  28. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology. 2006;241:449
  29. Swindle P, McCredie S, Russell P, et al. Pathologic characterization of human prostate tissue with proton MR spectroscopy. Radiology. 2003;228:144

PII: S0009-9260(08)00085-8

doi: 10.1016/j.crad.2007.10.020

Clinical Radiology
Volume 63, Issue 8 , Pages 871-879 , August 2008

Article Tools

* Image Usage & Resolution